Companies · Other Health Care

Renerva LLC

PITTSBURGH · Other Health Care

Diligence memoA one-page analyst read on Renerva LLC — recommendation, valuation, rhythm, risks.
$1.3M
Total raised · real
3
Rounds
1.0×
Latest step-up
Top 62%
Sector rank · raised
Seed
Latest stage · inferred · Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Renerva LLC looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.20× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Active
  • Last raise 9 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Renerva LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
8.0 yr record
Peak capital year was 2024 with $1.8M across 2 filings.
Market position
ahead of 39% of Other Health Care peers
Capital scale is ahead of 39% of Other Health Care peers; modeled value is above 5% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2024: $1.8M across 2 filings.
  • Largest single filing was $1.5M on 2024-06-27.
  • Filing rows sum to $2.8M, while canonical raised total is $1.3M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Renerva LLC is one of 5376 Other Health Care companies tracked from PITTSBURGH. By capital raised it ranks in the long tail (ahead of 39% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
35
Investors (latest)
2025-09-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2018-06-17 Raised $617K (real) Modeled valuation $19M (est)$617K$19MPre-Seed2018Seed · 2024-06-27 Raised $1.5M (real) Modeled valuation $6.7M (est)$1.5M$6.7MSeed2024Seed · 2024-07-12 Raised $335K (real) Modeled valuation $1.5M (est)$335K$1.5MSeed2024Seed · 2025-09-15 Raised $325K (real) Modeled valuation $858K (est)$325K$858KSeed2025+$1.5M+$335K+$325KCumulative $2.8M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$617K · 2018
Seed$1.5M · 2024
Seed extension$335K · 2024
Seed extension$325K · 2025

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$858K
Base estimate est.
$275K
Conservative case
$1.6M
Upside case
$1.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $19.0M · 2018-06-172018Seed · modeled $6.7M · 2024-06-27Seed · modeled $1.5M · 2024-07-12Seed · modeled $858K · 2025-09-152025
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
0.8 yr
Elapsed time used
0.8 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
29 mo
Avg between rounds
$176K/yr
Capital velocity
8.0 yr
On record since
2018
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.5× of median
This company$1.3M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.2× of median
This company$325K
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$858K
Sector median$22.1M

Raised more than 39% of sector peers (real $). Modeled value above 5% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #88 of 105.

This companyCohort peer
$100K$1.0M$10.0M$100.0M$100K$1.0M$10.0M$100.0MCapital raised (log)Xymogen, Inc. · Seed Raised $62.4M · modeled $12.3M (est)Willow Life Sciences, Inc. · Seed Raised $4.0M · modeled $12.0M (est)ManyClicks, Inc. · Seed Raised $4.0M · modeled $11.6M (est)Sterile State, Inc. · Seed Raised $3.2M · modeled $11.4M (est)Limber Prosthetics, Inc. · Seed Raised $3.8M · modeled $11.1M (est)Othership Inc. · Seed Raised $3.7M · modeled $11.0M (est)Ps-Fertility, Inc. · Seed Raised $3.5M · modeled $11.0M (est)Eagle Onsite, Llc · Seed Raised $3.5M · modeled $10.6M (est)ForCast Orthopedics, Inc. · Seed Raised $3.8M · modeled $10.6M (est)1888 Equity LLC · Seed Raised $3.0M · modeled $10.5M (est)Arrellio, Inc. · Seed Raised $3.5M · modeled $10.0M (est)Kindbridge Corp · Seed Raised $5.4M · modeled $9.9M (est)Renerva LLC (this company) Raised $1.3M · modeled $858K (est)Renerva LLC
CompanyStageRaised · realValue · estvs peer med.
Xymogen, Inc.Seed$62.4M$12.3M2.89×
Willow Life Sciences, Inc.Seed$4.0M$12.0M2.84×
ManyClicks, Inc.Seed$4.0M$11.6M2.75×
Sterile State, Inc.Seed$3.2M$11.4M2.70×
Limber Prosthetics, Inc.Seed$3.8M$11.1M2.63×
Othership Inc.Seed$3.7M$11.0M2.61×
Ps-Fertility, Inc.Seed$3.5M$11.0M2.59×
Eagle Onsite, LlcSeed$3.5M$10.6M2.51×
ForCast Orthopedics, Inc.Seed$3.8M$10.6M2.50×
1888 Equity LLCSeed$3.0M$10.5M2.48×
Arrellio, Inc.Seed$3.5M$10.0M2.35×
Kindbridge CorpSeed$5.4M$9.9M2.33×
Renerva LLC this companySeed$1.3M$858K0.20×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$617K2018-06-17$3.4M$19.0M90%
Seed$1.5M2024-06-27$7.5M$6.7M90%
Seed$335K2024-07-12$1.7M$1.5M90%
Seed$325K2025-09-15$1.6M$858K90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$617K2018-06-17
    • First recorded raise — entered as Pre-Seed.
    • 12 investors on this round.
  2. Seed$1.5M2024-06-27
    • Raised again after 72 mo — slower than the ~14 mo sector norm.
    • Round 2.4× larger than the prior — scaling up.
  3. Seed$335K2024-07-12
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 4.5× smaller than the prior — bridge or down round.
    • 14 investors on this round.
  4. Seed$325K2025-09-15
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 35 investors on this round.
Intelligence
2028 ~Q1
Modeled next raise · ~29mo cadence
$325K
Modeled next size est.range $325K$520K
1.0×
Last step-up
$176K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
J. Christopher Flaherty1 other2018-06
Bryan N. Brown2018-06
Jonathan N. Cheetham2018-06
Lorenzo Soletti2018-06
Paul A Gardner2018-06
Peter N. DeComo2024-06
William A Sekkel2024-06
Registry & provenance

Renerva LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1748198
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Emerald Coast Surgery Center L POther Health CareSeed$1.4M$1.0Msame sector · same stage
Golden Triangle SurgiCenter, L.P.Other Health CareSeed$1.5M$891Ksame sector · same stage
Navierre Holdings, LLCOther Health CareSeed$1.1M$923Ksame sector · same stage
Amity Holdings, LLCOther Health CareSeed$1.9M$1.2Msame sector · same stage
Surgicare Of Jackson, Ltd.Other Health CareSeed$2.1M$785Ksame sector · same stage
Rose Management Group Inc.Other Health CareSeed$2.1M$1.2Msame sector · same stage
Ten Mile Surgery Center, LLCOther Health CareSeed$2.1M$1.1Msame sector · same stage
Structural Elements Franchising, LLCOther Health CareSeed$2.3M$1.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Curegrail, LlcOther Health CareSeed$49.6M83%
Regenexx, LLCOther Health CareSeries A$201.8M81%
CurvaFix, Inc.Other Health CareSeries C$477.8M81%
Illuma, LLCOther Health CareSeed$37.2M81%
Auxthera, LLCOther Health CareSeed$49.6M81%
Aba Dso, LlcOther Health CareSeries A$121.1M81%
Alignera LlcOther Health CarePre-Seed$502K81%
Arivale Inc.Other Health CareSeries B$301.3M81%
Frequently asked
How much funding has Renerva LLC raised?
Renerva LLC has raised approximately $1.3M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Renerva LLC's estimated valuation?
Provath's modeled valuation for Renerva LLC is approximately $858K (modeled range $275K–$1.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Renerva LLC at?
Renerva LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Mon Sep 15.
What does Renerva LLC do and where is it based?
Renerva LLC operates in the Other Health Care sector, based in PITTSBURGH.
Explore related

See where Renerva LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Renerva LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.